biotech industry (their customers) has struggled with low valuations on new therapeutics and little ability to raise money. some green shoots with some deal making evident this year.
the biggest challenge is tax-loss selling season coming up. there is probably lower prices to come mid June for those on the sidelines such as myself.
biotech industry (their customers) has struggled with low...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRJ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
0.040(4.00%) |
Mkt cap ! $158.3M | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.04 | $1.01 | $27.28K | 26.52K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 2516 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| TRJ (ASX) Chart |